Marketresearchnews: Global Orphan diseases Market Industry Production and Demand, Competition News and Trends Forecasts to 2027
The global orphan drugs market is expected to exhibit a robust 11.5% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global orphan drugs market is mainly driven by the growing research into rare diseases and the growing government support to research and development into making orphan drugs. The global orphan drugs market is profiled in great detail in the research report, providing readers with a comprehensive overview of the market through its historical growth trajectory, present conditions, and future growth prospects.
Global Transdermal (Percutaneous) Drug Delivery Systems Market Industry Production and Demand, Competition News and Trends Forecasts to 2027
The global transdermal (percutaneous) drug delivery systems market held a market value of USD 5,400.2 million in 2017 and is projected to grow at a CAGR of 4.6% over the forecast period. Transdermal drug delivery system (TDDS) delivers drugs into systemic circulation into the skin through the skin at a predetermined rate with minimal inter and intrapatient variation. TDDS has emerged as a potential novel drug delivery system in the past couple of decades to improve the therapeutic efficacy and safety, maintain a steady state plasma level of drugs and overcome disadvantages of the conventional oral dosage forms and parenteral preparations. Some of the major factors driving the market growth are rapid technological advancements in transdermal drug delivery systems and increasing adoption of third-generation delivery systems, the growing geriatric population along with the rise in prevalence of chronic diseases across the world.
Marketresearchnews: Global Pain Management Market Industry Production and Demand, Competition News and Trends Forecasts to 2027
Regional Analysis The Americas dominates the pain management market owing to the increasing prevalence of chronic pain, well-developed technology, high healthcare expenditure, and the presence of leading players. According to a study published in the Drug and Alcohol Dependence Journal in 2017, more than 100 million adult Americans are living with chronic pain. Chronic low back pain and headaches are the most commonly diagnosed conditions. It is also stated that such conditions are more prevalent in women than men, i.e., 34.3% in women, and 26.7% in men in the United States.
Marketresearchnews: Transdermal (Percutaneous) Drug Delivery Systems Market Dynamics, Segments and Supply Demand 2020-2027
Few of the technological advancements in the TDDS are transdermal patch design modification, incorporation of pressure sensitive adhesives and permeation enhancers that results in the enhancement of drug diffusion and increased the capacity to hold the drug in larger amount are expected to propel the demand for TDDS during the forecast period. Technological inventions such as the inclusion of microneedles or mechanical arrays in transdermal patches and miniaturized and advanced transdermal patches and reservoir type transdermal patches that deliver precise medication dose are expected to facilitate the market growth during the forecast period. Regional Analysis
Marketresearchnews: Global Pharmacovigilance Market size and forecast, 2020-2027
Segmentation The Global Pharmacovigilance Market has been segmented based on the clinical trial phase, service provider, type, and end-user. The market, based on the clinical trial phase, has been divided into phase IV, phase III, phase II, phase I, and pre-clinical. Phase IV segment dominated the pharmacovigilance market as adverse drug reactions are majorly detected in this phase. Whereas, phase III is expected to witness the fastest growth. The global pharmacovigilance market has been segmented, on the basis of service provider, into in-house and contract outsourcing.
Global Transdermal (Percutaneous) Drug Delivery Systems Market Show Steady... — Zen Writing
Global Transdermal (Percutaneous) Drug Delivery Systems Market Show Steady Growth: Study 2027 The global transdermal (percutaneous) drug delivery systems market held a market value of USD 5,400.2 million in 2017 and is projected to grow at a CAGR of 4.6% over the forecast period. Transdermal drug delivery system (TDDS) delivers drugs into systemic circulation into the skin through the skin at a predetermined rate with minimal inter and intrapatient variation. TDDS has emerged as a potential novel drug delivery system in the past couple of decades to improve the therapeutic efficacy and safety, maintain a steady state plasma level of drugs and overcome disadvantages of the conventional oral dosage forms and parenteral preparations.
Marketresearchnews: Healthcare Analytics Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027
Regional Analysis Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Geographically, the Americas is anticipated to dominate the global healthcare analytics market owing to presence of well-established players in the, well-established penetration of information technology in the field of healthcare, for instance, according to reports by the Centers for Disease Control and Prevention in 2017, approximately 86.9% of the hospital-based physicians used the EMR/EHR system.
Transdermal (Percutaneous) Drug Delivery Systems Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis And Forecast To 2027
Few of the technological advancements in the TDDS are transdermal patch design modification, incorporation of pressure sensitive adhesives and permeation enhancers that results in the enhancement of drug diffusion and increased the capacity to hold the drug in larger amount are expected to propel the demand for TDDS during the forecast period. Technological inventions such as the inclusion of microneedles or mechanical arrays in transdermal patches and miniaturized and advanced transdermal patches and reservoir type transdermal patches that deliver precise medication dose are expected to facilitate the market growth during the forecast period. Regional Analysis The global transdermal (percutaneous) drug delivery systems market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas spearheaded the global transdermal (percutaneous) drug delivery systems market in 2017.
Marketresearchnews: Hematology Diagnostics Market size in terms of volume and value 2020-2027
Market Highlights The renewed emphasis on health and wellness has prompted an increased focus on blood-related disorders as well. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is set to profit from the positive CAGR in the market during the forecast period. The increased prevalence of blood-related disorders is motivating the expansion of the hematology diagnostics market. Moreover, the development in the detection and diagnostic methods has improved the growth of the market for hematology diagnostics.
Transdermal (Percutaneous) Drug Delivery Systems Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027
The global transdermal (percutaneous) drug delivery systems market held a market value of USD 5,400.2 million in 2017 and is projected to grow at a CAGR of 4.6% over the forecast period. Transdermal drug delivery system (TDDS) delivers drugs into systemic circulation into the skin through the skin at a predetermined rate with minimal inter and intrapatient variation. TDDS has emerged as a potential novel drug delivery system in the past couple of decades to improve the therapeutic efficacy and safety, maintain a steady state plasma level of drugs and overcome disadvantages of the conventional oral dosage forms and parenteral preparations. Some of the major factors driving the market growth are rapid technological advancements in transdermal drug delivery systems and increasing adoption of third-generation delivery systems, the growing geriatric population along with the rise in prevalence of chronic diseases across the world. Regional Analysis
